Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07593274 · ClinicalTrials.gov registry record · NA
Continuing Care for Justice-involved Individuals
A NA study, sponsored by Friends Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT07593274: Completed NA study, sponsored by Friends Research Institute.
NCT07593274 is a NA study that has completed, run by Friends Research Institute. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07593274, a NA study, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The goal of this open label feasibility trial is to determine the feasibility of using a mobile continuing care app to augment community treatment for individuals under justice supervision receiving community substance use disorder treatment.
Primary Outcome
Questions about usability will be asked using the System Usability Scale (SUS), one of the most widely used standardized measures to assess technology usability. Using this scale, participants are asked to provide a score for 10-items, using 5-point Likert scales, regarding: a) ease of use, and b) learnability.
Interventions
- DEVICE continuing care app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the finished NCT07593274 record still lists
NCT07593274 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which continuing care app is the first listed.
NCT07593274 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07593274 about?
NCT07593274 is a clinical study titled "Continuing Care for Justice-involved Individuals". The goal of this open label feasibility trial is to determine the feasibility of using a mobile continuing care app to augment community treatment for individuals under justice supervision receiving community substance use disorder treatment.
What is the current status of trial NCT07593274?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2025-05-08. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT07593274?
The interventions under investigation include: continuing care app (DEVICE).
Who is sponsoring clinical trial NCT07593274?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07593274's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI